Vancouver, British Columbia--(Newsfile Corp. - April 3, 2024) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") is pleased to announce that it intends to hold its annual general meeting of shareholders (the "Meeting") on May 10, 2024 in Vancouver, British Columbia. The specific time, location and format of the Meeting will be provided in the Company's notice of meeting and management information circular, which will be filed on the Company's SEDAR profile at https://www.sedarplus.ca/ in advance of the Meeting in accordance with applicable securities law. The close of business on April 3rd, 2024 has been fixed as the record date for the determination of shareholders entitled to receive notice of and to vote at the Meeting.

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2024) - Further to Solarvest's (TSXV: SVS.H) (or "the Company"s) press releases dated May 3, 2023 and July 24, 2023 and to the Exchange's Notice to transfer to NEX dated September 15, 2023, the Company confirms that the Exchange has issued a bulletin to transfer the Company's securities to NEX effective at the opening on Tuesday, January 9, 2024. Currently, trading remains suspended.

Vancouver, B.C – TheNewswire - Decemder 7th 2023 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), wish to provide clarity to shareholders regarding the process to elect a new board of directors. On behalf of shareholders a shareholder will apply to the court to request a shareholder meeting to elect a new board of directors as required under the BC Corporation act.

Vancouver, British Columbia – TheNewswire - December 1st, 2023 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), reports the resignation of the  entire board of directors and officers of the company.  A number of factors contributed to the resignation, including the expiration of the director’s liability insurance whereby renewal terms with the existing insurer were unacceptable to the Board.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./

VANCOUVER, BC, Sept. 5, 2023 /CNW/ - The following issues have been halted by CIRO

Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that, further to its news release of August 3, 2023, a Notice of Requisition for General Meeting delivered by Garth Greenham and LMC Communications Inc. dated July 24, 2023 has been recognized as valid by the Company and accordingly has scheduled a meeting of shareholders (the "Meeting") for November 24, 2023 in accordance with the provisions of the Business Corporations Act (British Columbia).

Vancouver, British Columbia--(Newsfile Corp. - August 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces, that a notice of requisition of a general meeting of shareholders (the "Requisition") was delivered to the registered office of the Company on July 24, 2023.

Vancouver, British Columbia--(Newsfile Corp. - July 27, 2023) - The Company (TSXV: SVS) is very pleased to announce that it has received Notice of Allowance and Notice of Allowability from the U.S. Patent & Trademark Office for it US Algal Juice Media Patent Application, U.S. Patent Application No.: 14/896,809 - METHODS AND PRODUCING ALGAL CELL CULTURES AND BIOMASS, LIPID COMPOUNDS AND COMPOSITIONS, AND RELATED PRODUCTS - RIVEROLL et al.

Vancouver, British Columbia--(Newsfile Corp. - July 24, 2023) - Further to press release dated May 3, 2023, the TSX Venture Exchange ("TSX-V") requested Solarvest (TSXV: SVS) (or "the Company") to provide a detailed analysis, subject to review and acceptance, to meet Tier 2 Continued Listing Requirements ("CLR") by July 20, 2023.

Vancouver, British Columbia--(Newsfile Corp. - May 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") wishes to provide an update regarding its corporate activities.

VANCOUVER, BC, April 20, 2023 /CNW/ - Trading resumes in:

VANCOUVER, BC, April 19, 2023 /CNW/ - The following issues have been halted by IIROC:

Vancouver, British Columbia--(Newsfile Corp. - April 19, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") wishes to provide an update regarding its corporate activities.

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") wishes to report that it has filed its interim financial results for the six-month period ended January 31, 2023. Solarvest's financial statements (the "Financial Statements") are prepared in accordance with International Financial Reporting Standards. Full copies of the Financial Statements, accompanying management discussion and analysis ("MD&A") and officer certifications are available on www.sedar.com.

Vancouver, British Columbia--(Newsfile Corp. - March 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") is pleased to announce that, further to its news releases of September 22 and November 3, 2022, the TSX Venture Exchange (the "Exchange") has accepted for filing its new fixed stock option plan (the "2022 Plan"). The 2022 Plan reserves a total of 11,067,000 common shares for issuance pursuant to the grant of stock options. All outstanding options from the Company's previous stock option plan have been rolled into the 2022 Plan effective March 1, 2023 and will be governed by its terms. Although disinterested shareholder approval for the 2022 Plan was obtained at the annual meeting of shareholders held on October 25, 2022, due to certain revisions required by the Exchange, further disinterested shareholder approval is required to be obtained at the next meeting of shareholders.

Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest", or the "Company"), is pleased to announce that, further to its news release of February 9, 2023, it has received final acceptance from the TSX Venture Exchange ("Exchange") for its previously announced non-brokered private placement (the "Offering") which closed in two tranches on December 16, 2022 (the "First Tranche") and February 7, 2023 (the "Second Tranche") respectively for aggregate gross proceeds of $541,900 from the sale of 5,419,000 units (the "Units") at a price of CDN$0.10 per Unit. Please refer to the Company's news releases dated December 8 and 20, 2022 and January 23 and February 9, 2023 for details of the Offering.

VANCOUVER, BC, Feb. 14, 2023 /CNW/ - 

Vancouver, B.C. - TheNewswire - February 9, 2023 –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”) announces that, further to its news release of January 23, 2023, the Company has closed a further tranche of its previously announced non-brokered private placement for gross proceeds of $81,000 from the sale of 810,000 units (the “Units”). Together with the previously closed tranche announced on December 20, 2022, the Company has raised gross proceeds of $541,900 through the issuance of 5,419,000 Units at a price of CDN$0.10 per Unit (the “Of

Vancouver, BC - TheNewswire - January 31, 2023 - Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), announces that Leslie Auld has been appointed the company’s Chief Financial Officer effective January 30, 2023.

Vancouver, B.C. - TheNewswire - January 24th, 2023  –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces that it has been granted a patent for Organic omega-3 in Brazil.  The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins.  This patent adds additional strength to the Company’s existing patent portfolio as it commercializes its line of organic Omega-3 products.  Brazil is the l

Vancouver, B.C., January 22, 2023  – TheNewswire - Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”) announces that the Company has been granted an extension by the TSX Venture Exchange (the “TSXV”) to February 8, 2023 to complete a previously announced non-brokered private placement (the “Offering”) (see the Company’s news release of December 8, 2022). In addition, the TSXV has approved an increase in the total size of the Offering to CDN$1 million. A first tranche of the Offering raising over $460,000 has already closed (see the Company’s ne

Vancouver, BC - TheNewswire - December 20, 2022 - Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”) is very pleased to announce that, further to its news releases of October 20 and December 8, 2022, it has closed a first tranche (the “First Tranche”) of a non-brokered private placement (the “Offering”) through the issuance of 4,609,000 units (a “Unit”) for gross proceeds of $460,900.

Vancouver, BC - TheNewswire - December 8, 2022 - Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), wishes to provide an update to its news release of October 20, 2022 regarding a non-brokered private placement, pursuant to which the Company intends to raise gross proceeds of up to $650,000 through the issuance of up to 6,500,000 Units at a price of $0.10 per Unit (the “Offering”). The Company is currently settling a final subscriber list and will shortly be seeking conditional approval from the TSX Venture Exchange to close the Offering.

Vancouver, B.C. – TheNewswire – December 6, 2022 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS) is pleased to announce that, through its wholly-owned subsidiary, Eversea Inc. (“Eversea”), it has exercised a purchase option agreement (the “Purchase Option”) on lands and an industrial building it has been leasing from the PEI provincial government. This purchase will allow the Company to continue its R&D work as well as providing a permanent facility for commercial production of algae for its Omega-3 product line. The building is 3332.8 m2 (35,875 ft2) and is situated

Vancouver, B.C. – TheNewswire - November 3, 2022 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”) is pleased to announce that at the Annual and Special Meeting of shareholders held on October 25, 2022 (the “Meeting”), Solarvest shareholders approved the re-appointment of Arsenault Best Cameron Ellis, Chartered Professional Accountants as auditors and re-elected the existing board of directors. Disinterested shareholders also overwhelmingly approved the 2022 Stock Option Plan and ratified the re-pricing of stock options previously granted to

Vancouver, B.C., - TheNewswire - October 20, 2022  –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces a non-brokered private placement, pursuant to which the Company intends to raise gross proceeds of up to $650,000 through the issuance of up to 6,500,000 Units at a price of $0.10 per Unit.  Each Unit consists of one common share and one whole share purchase warrant.  Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.20 per share for a period of two (2) years following cl

Vancouver, B.C. – TheNewswire - October 18, 2022 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces that Mr. Claes Ellegaard has been appointed the Company’s Chief Executive Officer effective October 7, 2022.

Vancouver, B.C. - TheNewswire - October 4, 2022 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces the Board of Directors has mandated the management of Solarvest including the Advisory Committee to evaluate different scenarios to be presented shortly to the Board of Directors in order to accelerate the development of the successful proof of concept of the Company’s Green Bio-Hydrogen.

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2022) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that pursuant to the Company's existing Stock Option Plan, a total of 1,000,000 incentive stock options have been granted to a consultant of the Company. These stock options are exercisable at a price of $0.12 per share for a period of 2 years expiring August 1, 2024.

Vancouver, B.C. - TheNewswire - July 14th. 2022 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV:SVS) is pleased to announce that has formed added two people to the Advisory Board - Max Goldberg and Jerome Cliché (bio’s below). “The addition of additional public market(s) experience and extensive organic industry expertise gives the Advisory Committee a wealth of experience and knowledge,” said Richard Groome. He continued, “The committee will start immediately with regular meetings to support the company’s initiatives in marketing and the public markets.”  

Vancouver, B.C., - TheNewswire - July 7th, 2022 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV:SVS) is very pleased to announce that Richard Groome has agreed to chair the Company’s newly created financial advisory committee (the “Advisory Board”) and to support the recruitment of two additional members. The Advisory Committee will offer knowledge and skills in relation to fundraising, strategic acquisitions, marketing and to connect Solarvest with potential investors, customers, partners, service providers, employees and media.

Vancouver, B.C. - TheNewswire - June 28, 2022 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSX:SVS) is pleased to announce that its 3rd quarter statements for the period ended  April 30, 2022, related management discussion and analysis have been filed and are now available on www.sedar.com.

Vancouver, B.C. - TheNewswire - April 4, 2022 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), is pleased to announce that its wholly-owned division Eversea America Inc. (“Eversea”) has signed an agreement with E3Live, one of the organic industry’s premier superfood brands. E3Live has agreed to introduce and market Eversea's organic omega-3 DHA products to its customer base.

Vancouver, B.C. - TheNewswire - March 17, 2022  –  Solarvest BioEnergy Inc. (“Solarvest", or the "Company") (TSXV:SVS), (“Solarvest” or the “Company”), announces that it has been granted a patent in Japan.  The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids, and fat-soluble vitamins.  This patent adds additional strength to the Company’s existing patent portfolio as it commercializes its line of organic Omega-3 products.  

Vancouver, B.C. - TheNewswire - January 12, 2022 – Solarvest (TSXV:SVS) is pleased to announce that the EverseaTM “branded” account has been launched on the Chinese e-commerce platform application Redbook.  

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2021) - Solarvest BioEnergy Inc. ("Solarvest" or the "Company") (TSXV: SVS) is pleased to announce that its quarterly statements for the period ended October 31, 2021, related management discussion and analysis have been filed and are now available on www.sedar.com.

Vancouver, B.C. - TheNewswire - December 1st, 2021 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV:SVS)

Vancouver, B.C. - TheNewswire - November 19th, 2021 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV:SVS) is pleased to announce that its audited financial statements for the year ended July 31, 2021, related management discussion and analysis and associated officer's certifications (collectively, the "Annual Filings") have been filed and are now available on www.sedar.com.

 Vancouver, B.C. - TheNewswire - October 20th, 2021–  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSX-V:SVS), is pleased to report, that its wholly owned subsidiary EverseaTM Inc. has completed a suite of unique Organic Omega-3 shots.  The functional shots market is expected to grow at 16% per year to 1.4 billion in 2027 according to Research and Markets*. The company’s convenient 60 ml. shots are formulated to supplement the essential daily Omega-3 requirement with added organic ingredients.  For example, Stamina includes ingredients that are known to dilate blood vessels, an e

Vancouver, B.C. - TheNewswire - October 6th, 2021–  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), is pleased to report, that through its wholly owned subsidiary Eversea, the launch of a Chinese social media promotion program and the development of a line of products for distribution in the USA and through OrgHive in China. The products include the company’s proprietary organically produced and FDA NDI #861 approved Omega-3 as the foundation for the entire range of products.  The four new blended powder products are Daily Omega, Stamina, Recovery and Vision.  All are for

Vancouver, BC – TheNewswire - September 10, 2021 – Solarvest Bioenergy Inc. (“Solarvest” or the “Company”) (TSXV:SVS) held its annual general meeting of shareholders (the “Meeting”) on Wednesday, September 8. A total of 19,294,920 common shares (representing 34.87% of all issued and outstanding common shares of the Company) were represented at the Meeting. Shareholders of the Company (the “Shareholders”) voted in favor of all items of business put forth at the Meeting.

Vancouver, B.C. - TheNewswire - September 1st, 2021–  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), - Solarvest BioEnergy Inc. is pleased to announce that its wholly owned division, Eversea Inc., has signed sales and promotional agreements with OrgHive, China’s leading digital marketing and e-commerce platform dedicated to organic consumers.

Vancouver, B.C. - TheNewswire - August 24th, 2021 -  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), The company is please to offer this operational update.  The company has advanced on many fronts since the recent financing.  The focus has been on expansion of the organic Omega-3 product line for white label sales to large and influential companies based in the USA.  The initial response has been positive as many companies are formulating with our ingredient and assessing our value-added products

Vancouver, B.C. - TheNewswire - July 27th, 2021 –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), has entered into an advertising and investor awareness campaign with Dig Media Inc. dba Investing News Network (INN). INN is a private company headquartered in Vancouver, Canada, dedicated to providing independent news and education to investors since 2007. For the 13 month term of the agreement, INN will provide advertising to increase awareness of the issuer. INN does not provide Investor Relations or Market Making services.

Vancouver, B.C. - TheNewswire - July 20th, 2021 –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS) , is pleased to announce that its subsidiary, Eversea Inc., has entered into a contractual agreement with Canada’s Smartest Kitchen to develop a formulation for a nutritional-enhancing ingredient based on Eversea’s patented organic DHA powder. This mixture can be used by companies who are producing plant-based seafoods which require Omega-3s to compete in the fish and shellfish marketplace.  Canada’s Smartest Kitchen’s expertise in food science, ingredients and flavours makes

Vancouver, BC – TheNewswire - June 22, 2021 - SOLARVEST BIOENERGY INC. (TSXV:SVS) ("Solarvest" or the “Company”), announces that it has amended certain stock option grants previously disclosed in its News Release of February 19, 2021. Of the 3,360,000 options granted to purchase 3,360,000 common shares of the Company, 1,400,000 options will be granted to Insiders of the Company. Subsequent to the closing of a private placement announced on April 20, 2021, there is no longer an officer and director who is also a Control Person of the Company.

Vancouver, B.C. - TheNewswire - May 27, 2021  –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), is pleased to announce, that as part of its operational  expansion program, the Company has added key personnel.  These positions will be required as production volumes increase to allow the company more control over quality control and scheduling, and increase the profitability of the finished product. Additionally, the Company will be better able to facilitate the development and scale up of new products using its proprietary processes while ensuring organic and cGMP complia

Vancouver, B.C. - TheNewswire - May 25, 2021  – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces that its EverseaTM Inc. division has signed an agreement with MRF Associates Inc. to represent the Company in Brazil. Under the agreement MRF will use its extensive background and relationships to introduce SVS Organic Omega-3 products and ingredients into the Brazil marketplace.

Vancouver, B.C. - TheNewswire - April 27, 2021  –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS) (“Solarvest” or the “Company”), announces that it has been granted patents in Australia and India.  The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins.  These patents add additional strength to the Company’s existing patent portfolio as it commercializes its line of organic Omega-3 products.  

Vancouver, B.C. - TheNewswire - April 20th, 2021 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), is very pleased to announce that, further to its news release of March 26th, 2021, it has closed a private placement through the issuance of 9,189,147 units (a “Unit”) for gross proceeds of $2,297,286. The placement closed in two tranches: 3,465,448 Units were issued on March 26th and 5,723,699 Units were issued on April 16th, 2021. Each Unit consists of one common share (a “Common Share”) and one whole share purchase warrant (a “Warrant”).  Each Warrant entitles the holder

Vancouver, B.C. - TheNewswire - April 6th, 2021 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), is pleased to announce that it and The Scoular Company (“Scoular”) are exploring a potential business relationship related to developing a sustainable supply of Omega-3 fatty acids, a globally important and limited resource, through a non-binding development program.    The goal of the program is to develop protocols and process data for the efficient production of commercial volumes of Omega-3 fatty acids.  

Vancouver, B.C. - TheNewswire - March 26, 2021  –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSX-V:SVS), (“Solarvest” or the “Company”) is pleased to announce that, due to unprecedented investor demand, it has increased the maximum offering size of a previously announced non-brokered private placement to 9,000,000 units at a price of $0.25 per unit for gross proceeds of up to $2,250,000. On March 17, 2021, the Company has announced its intention to conduct a private placement for up to 8,000,000 units for gross proceeds of $2,000,000.

Vancouver, B.C. - TheNewswire - March 17, 2021  –  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces a non-brokered private placement, pursuant to which the Company intends to raise gross proceeds of up to $2,000,000 through the issuance of up to 8,000,000 Units at a price of $0.25 per Unit.  Each Unit consists of one common share and one whole share purchase warrant.  Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.35 per share for a period of one (1) year following clos

Vancouver, BC – TheNewswire - February 19, 2021 - SOLARVEST BIOENERGY INC. (TSXV:SVS) ("Solarvest" or the “Company”), is pleased to announce that, in accordance with the Company's Stock Option Plan, it has granted to certain directors, officers, employees and consultants, incentive stock options to purchase up to an aggregate of 3,360,000 common shares exercisable at a price of $0.40 per share for a period of three years from the grant date.  Of these stock options, 1,600,000 will be granted to Insiders of the Company, including a grant of 425,000 options to an officer and director who is als

February 2, 2021 – TheNewswire - EverseaTM America Inc. (“Eversea” or the “Company”) (TSXV:SVS) is pleased to announce launch of the world’s first and only organic certified Omega-3 DHA chewable for children. The product is a unique first offering for Eversea, using the world’s only EU and USDA organic certified DHA ingredient NanuqTM Omega3 100 (pronounced Na Nook).  This patented ingredient is the product of 7 years of research and development into the development of ocean-based Omega-3 without using chemical process aids/additives, solvents or heavy industrial processes. We grow the produc

Vancouver, B.C. - TheNewswire - February 01, 2021 - SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to provide an update to the December 21, 2020 press release of its highly-bioavailable Organic Omega-3 Children’s Supplement. The product, marketed under the Company’s Eversea brand, is the world’s first and only Organic Omega-3 children’s fruit drop. Eversea seeks to benefit from the extensive and growing market demand for organic, vegetarian and vegan diets.  Eversea’s organically certified supplement holds a competitive advantage with several differentiating fa

Vancouver, B.C. - TheNewswire - January 14, 2020 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS) announces that further to its news release dated January 6, 2021, it has received the TSX Venture Exchange Final Approval for the Shares for Debt Transaction whereby 525,000 Common Shares of the Company were issued in order to settle a debt of $73,500.

Vancouver, B.C. - TheNewswire - January 5th. 2021 – SOLARVEST BIOENERGY INC. (TSXV:SVS)  (“Solarvest” or the “Company”), is pleased to announce the addition of Greg Drohan to its Board of Directors. Mr. Drohan will join the Board in early 2021.

Vancouver, B.C. - TheNewswire - December 21st, 2020  -  Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), Solarvest, through it’s 100% wholly owned subsidiary EverseaTM is pleased to announce plans to launch its Organic Omega-3 nutritional Gummy Fruit Drops for children after the year-end holiday break.  The fruit drop has been produced and passed quality control under high standards from our German contract manufacturer.  The final phase is to confirm the quality of the product after the logistics of shipping and packaging which is underway.  The Company’s first of its kin

Vancouver, B.C. - TheNewswire - December 18th 2020  – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), Solarvest, is pleased to provide this operational update.  

Vancouver, B.C. - TheNewswire - September 29th 2020 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), is pleased to announce that it has produced its first commercial batch of proprietary organic Omega-3 powdered supplement, a global first. This production was completed using the Company’s patented process and European contract manufacturers. The product is high in DHA (an essential nutrient), and is sustainable, plant-based, EU and USDA certified organic. The product has been reviewed and approved for interstate commerce by the United States FDA as a New Dietary Ingredie

Vancouver, B.C. - TheNewswire - September 18, 2020 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS) announces that further to its news release dated August 27, 2020, it has received the TSX Venture Exchange Final Approval for the Shares for Debt Transaction whereby 1,007,600 Common Shares of the Company were issued in order to settle a debt of $100,760.

Vancouver, BC – TheNewswire - August 27, 2020 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (the “Company” or “Solarvest”) announces that it has arranged the settlement of up to (i) $100,760 of debt through the issuance of common shares of the Company and (ii) $20,020 of debt through cash payment (the “Debt Settlement”). The sum of $120,780 is recorded in the Company’s financial statements, which is due to consulting and advisory service providers (the “Creditors”). Pursuant to the Debt Settlement, the Company would issue up to 1,007,600 common shares of the Company (the Shares”) at a deemed price of

Vancouver, B.C. - TheNewswire – August 24 2020 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), is pleased to announced that the Company’s German-based contractors have resumed normal operations after a slowdown related to the COVID-19 pandemic. The Company is now advancing toward commercial production of its patented Omega-3 products.

Vancouver, B.C. - TheNewswire - July 30, 2020 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”) today announced that its Chief Financial Officer Joseph Heng has resigned from the Company. The effective date of his resignation was July 23, 2020. The Company wishes Mr. Heng all the best in his retirement and wishes to thank him for all the years of service, financial support and sage advice.  

Vancouver, BC – TheNewswire - June 18, 2020 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), wishes to update its shareholders on the results of its Annual General Meeting held on June 8, 2020 in Vancouver, British Columbia. Shareholders voted in favour of all management resolutions proposed in the Management Proxy Circular and as listed below:

Vancouver, B.C. - TheNewswire - April 24, 2020  – SOLARVEST BIOENERGY INC. (TSXV:SVS) : The Company is working hard to ensure staff safety through staggered work schedules, social distancing in the workplace and isolation in our laboratories.  The company has also taken steps to shore up its financial stability to carry the company over this shutdown while moving developments forward.

Vancouver, B.C. - TheNewswire - March 4, 2020  – SOLARVEST BIOENERGY INC. (TSXV:SVS): Mr. Gerri Greenham is pleased to announce that the Chinese Patent Office has accepted claims for Solarvest’s cecropin based malaria biologic. This in addition to our Australian and USA issued patents. Third party trials were conducted at the Toronto University Health Network at MaRS generating data which furthered our research and IP program.  We would like to thank Dr. Ian Crandall for his expertise and support.  With the current global awareness of diseases malaria still remains one of the world’s most ser

TORONTO, ON – TheNewswire – February 4, 2020 – FSD Pharma Inc. (NASDAQ:HUGE) (CNSX:HUGE.CN) (FRA:0K9A)  (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSXV:SVS) (“Solarvest”) (collectively, the “Parties”), are pleased to announce that, further to their press release of May 7, 2019, the Parties have agreed to amendments to the Collaborative Research and Development Agreement  (the “Research Agreement”) designed to accelerate progress of the research project that Solarvest is carrying out (the “CBD Research Project”). Under the amended Research Agreement, FSD Pharma has agreed to issue additional

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”) (collectively, the “Parties”), are pleased to announce that, further to their press release of May 7, 2019, the Parties have agreed to amendments to the Collaborative Research and Development Agreement (the “Research Agreement”) designed to accelerate progress of the research project that Solarvest is carrying out (the “CBD Research Project”). Under the amended Research Agreement, FSD Pharma has agreed to issue additional class B subor

Vancouver, B.C. - TheNewswire - January 30th, 2020 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to announce that Edward J. Brennan, Jr., M.D., FACS, has accepted our invitation to become a member Solarvest’s Board of Directors.

Vancouver, BC – TheNewswire - December 2nd, 2019 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (the “Company”), is pleased to announce that it has received USDA organic certification for its EU/USA production process/contractors and it’s children’s organic fruit gummy Omega-3 supplement.  This certification coupled with the FDA approval already received will now allow the Company to move forward with marketing activities and production runs. The Company is working with its contractors to ensure the USDA specifications are covered in its manufacturing and packaging process.  

Vancouver, BC – TheNewswire - September 26th, 2019 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to announce that Dr. Azoy Kumar Kundu has joined Solarvest’s protein expression team.  His extensive background includes protein science and in-depth experience in genetic technologies.  He worked in a team that was successful in developing and receiving FDA approval for the world’s first GMO food animal.  

Vancouver, BC – TheNewswire - August 8th, 2019 - SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to update shareholders on the progress of its product development program designed to produce our first children’s organic DHA supplement in an organic fruit gummy format.  We have manufactured our first complete dried fruit gummy run.  This batch was used to formalize production protocols, quality control, labeling, regulatory approvals and other aspects of technology transfer necessary to arrive at our finished product.  

Vancouver, BC – TheNewswire - July 29th, 2019 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to announce that the European Dental Patent Application has now been allowed.   The claims are directed to whole genetically modified green microalgae for use in reducing dental plaque in animals, where the microalgae belong to the genus Chlamydomonas, Chlorella, Volvox, Dunalielia, Nannochloris and/or Oedogonium.

Vancouver, BC – TheNewswier - July 18th. 2019 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to announce that it has received EU organic certification for three new products.  First, the company’s algae cream has been approved by Lacon GmbH, second, AB CERT AG has certified the high Omega 3 algae powder and third, the company’s Gummy Drop (finished oral dosage form) has been organic approved by Ecocert IMO GmbH.  The organic logo can only be used on products that have been certified and the European Commission (EC) sets the strict standards for organic produc

Vancouver, BC / TheNewswire / June 20th. 2019 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), is pleased to announce that an additional patent has been granted in the United States for its key patent family titled ‘System, Method, and Device for The Expression or Repression of Proteins’.  The patent is related to the Company’s use of its algae platform and the claims have been granted for the production of clean hydrogen gas. The Company’s parent US patent in this patent family also covers the algal platform-based production of pharmaceutical grade human therapeutic pro

Vancouver, BC / TheNewswire / June 13, 2019 – SOLARVEST BIOENERGY INC. (TSX-V: SVS) (“Solarvest” or the “Company”), is pleased to announce that it has closed a non-brokered private placement, pursuant to which the Company raised $80,000 through the issuance of 400,000 Units at a price of $0.20 per Unit. Each Unit consists of one common share and one common share purchase Warrant.  Each Warrant entitles the holder to acquire one additional common share of the Company at a price of $0.25 per share for a period of three years following closing. In the event that the volume weighted average price

Vancouver, BC / TheNewswire / June 10, 2019 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), is pleased to announce Dr. Michael Thomas Horne BA PhD FRSB FCIM FIBMS CBiol CSci CMgt, a Fellow of Royal Society of Biology (UK), Fellow of Institute Biomedical Scientists, Fellow of the Chartered Institute of Management and Qualified Person (QIP Veterinary) is accepting the position of Head of Research leading the companies algae Bio-expression team.  

- Process Could Significantly Reduce Cannabinoid Production Time -

Vancouver, BC / TheNewswire / March 8, 2019 – SOLARVEST BIOENERGY INC. (TSX-V: SVS) (“Solarvest” or the “Company”),  has entered into the non-binding letter of intent with FSD Pharma Inc., which contemplates the parties entering into a Collaborative Research Agreement and ancillary documentation as described in the Company’s news release dated February 5, 2019.  The parties have agreed to extend the date for completion of definitive transaction documentation to Friday, April 5, 2019.

PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S)

Vancouver, BC / TheNewswire / January 24, 2019 – SOLARVEST BIOENERGY INC. (TSX-V: SVS) (“Solarvest” or the “Company”), announced the closing of the second tranche of its previously announced financing by way of news release dated January 22 2019.  The calculation of the commission payable to the brokers contained a calculation error.  The Company has paid a cash commission of $48,640 (previously disclosed $32,640) and 243,200 whole share purchase warrants (previously disclosed 163,200).  All other aspects of the financing remain as disclosed in the January 22 news release.  The Company has no

Vancouver, BC / TheNewswire / January 22, 2019 – SOLARVEST BIOENERGY INC. (TSX-V: SVS) (“Solarvest” or the “Company”), is pleased to announce that it has closed its second tranche of its previously announced financing.

Vancouver, BC / TheNewswire / December 14, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), announces that it has received an extension from the TSX Venture Exchange ("TSX-V") with respect to the duration of its private placement announced on November 1, 2018.  As a result, subject to regulatory approval, the closing date will now be on or about January 16, 2019.  

Vancouver, BC / TheNewswire / November 13, 2018 – SOLARVEST BIOENERGY INC. (TSX-V: SVS) (“Solarvest” or the “Company”), is pleased to announce that it has closed its initial tranche of its previously announced financing.

Vancouver, BC / TheNewswire / November 1, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), is pleased to announce a private placement, pursuant to which the Company intends to raise gross proceeds of up to $2,000,000 through the issuance of  up to 10,000,000 Units at a price of $0.20 per Unit.  Each Unit consists of one common share and one whole share purchase warrant.  Each whole warrant will entitle the holder to purchase one additional common share of the Company at a price of $0.25 per share for a period of three (3) years following closing (the “Private Placem

Vancouver, BC, / TheNewswire / July 27, 2018 – SOLARVEST BIOENERGY INC. (TSX-V: SVS) (“Solarvest” or the “Company”) announces that it has closed a non-brokered private placement, pursuant to which the Company raised $70,000 through the issuance of 350,000 Units at a price of $0.20 per Unit. Each Unit consists of one common share and one common share purchase warrant.  Each warrant entitles the holder to acquire one additional common share of the Company at a price of $0.25 per share for a period of three years following closing and includes an acceleration clause that is triggered by a 20 day

FOR IMMEDIATE RELEASE                                                                                        TSX-V:SVS

Vancouver, BC / TheNewswire / June 26, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), announces a non-brokered private placement, pursuant to which the Company intends to raise up to $300,000 through the issuance of  up to 1,500,000 Units at a price of $0.20 per Unit.  Each unit consists of one common share and one whole warrant.  Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.25 per share for a period of three years following closing and includes an acceleration clause that is triggered by a 20 day vo

Vancouver, BC / TheNewswire /  June 13, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest”) announces that it has settled the sum of US$43,651.52, which has been due to Barnes & Thornburg LLP in connection with legal services rendered in connections with the Company’s patents, by way of a shares for debt.  Pursuant to an agreement the total debt was settled through the issuance of 256,909 common shares at a deemed price of Cdn$0.22 per share.

Vancouver, BC / TheNewswire / June 8, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), announces it has closed its previously announced non-brokered private placement, pursuant to which an investor purchased from the Company an aggregate 400,000 Units at a price of $0.25 per Unit for gross proceeds of $100,000.  Each unit consists of one common share and one whole warrant.  Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.35 per share for a period of two years following closing and includes an acceleration

Vancouver, BC / TheNewswire / June 4, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest”), announces that it has arranged to settle by way of a shares for debt the sum of US$43,651.52 as recorded in its financial statements, which has been due to Barnes & Thornburg LLP in connection with legal services rendered in connections with the Company’s patents.  Pursuant to a letter agreement the total debt will be settled through the issuance of 256,909 common shares at a deemed price of $0.22 per share.

Vancouver, BC / TheNewswire / May 18, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), announces a non-brokered private placement, pursuant to which the Company intends to raise up to $100,000 through the issuance of  up to 400,000 Units at a price of $0.25 per Unit.  Each unit consists of one common share and one whole warrant.  Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.35 per share for a period of two years following closing and includes an acceleration clause that is triggered by a 20 day volume

Vancouver, BC / TheNewswire / March 26, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), is pleased to announce that it has closed on its previously announced financing (see the Company’s news release of January 11, 2018).  The Company has issued convertible debentures units (“Unit(s)”) for the aggregate gross proceeds of $1,000,000.  

Vancouver, BC / TheNewswire / February 27, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), announces that it has received a second extension from the TSX Venture Exchange ("TSX-V") with respect to the duration of its non-brokered private placement described in the Company’s news releases on January 11, 2018 and January 24, 2018.  As a result, subject to regulatory approval, the closing date will now be on or about March 27, 2018.  

Vancouver, BC / TheNewswire / January 24, 2018 – SOLARVEST BIOENERGY INC. (TSX-V:SVS) (“Solarvest” or the “Company”), announces that it has received an extension from the TSX Venture Exchange ("TSX-V") with respect to the duration of its non-brokered private placement announced on January 11, 2018.  As a result, subject to regulatory approval, the closing date will now be on or about February 26, 2018.  

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company"), announces it has completed a non-brokered private placement, pursuant to which the Company raised gross proceeds of up to $170,000 through the issuance of up to 680,000 Units at a price of $0.25 per Unit. Each unit consists of one common share and one whole warrant. Each whole warrant entitles the holder to acquire one additional common share of the Company at a price of $0.35 per share for a period of two years following closing and includes an acceleration clause that is triggered by a 20 day

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company"), announces it has completed a non-brokered private placement, pursuant to which the Company raised gross proceeds of up to $170,000 through the issuance of up to 680,000 Units...

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") announces that it intends to amend certain common share purchase warrants in the capital of the Company, which were issued pursuant to a private placement which closed in...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") announces that it intends to amend certain common share purchase warrants in the capital of the Company, which were issued pursuant to a private placement which closed in three tranches in December 2015, February 2016 and April 2016 (the "Warrants").

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") announces it has obtained a 30 day extension from the TSX Venture Exchange in order to complete its previously announced private placement financing with Drashta Ventures, a United Kingdom based impact investment fund ("Drashta").

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") announces it has obtained a 30 day extension from the TSX Venture Exchange in order to complete its previously announced private placement financing with Drashta Ventures, a...

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") is pleased to announce it has closed a first tranche of its previously announced private placement financing, with Drashta Ventures, a United Kingdom based impact investment...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") is pleased to announce it has closed a first tranche of its previously announced private placement financing, with Drashta Ventures, a United Kingdom based impact investment fund ("Drashta").

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") is pleased to announce it has arranged a private placement financing, for up to $1,000,000, with Drashta Ventures, a United Kingdom based impact investment fund...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") is pleased to announce it has arranged a private placement financing, for up to $1,000,000, with Drashta Ventures, a United Kingdom based impact investment fund ("Drashta").

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") reports that, further to the news release of October 14, 2016, the Company has received consent from the TSX Venture Exchange to extend the expiry date of certain common share...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") reports that, further to the news release of October 14, 2016, the Company has received consent from the TSX Venture Exchange to extend the expiry date of certain common share purchase warrants, which were issued pursuant to a private placement in April 2015 (the "Warrants").

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") announces that it intends to amend certain common share purchase warrants in the capital of the Company, which were issued pursuant to a private placement in April 2015 (the...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company"). Further to Solarvest's news releases on May 9, 2016 and August 18, 2016 with respect to its intention to complete a non-brokered $1,500,000 debenture and unit financing (the "Private Placement"), the Company announces that it has been unable to close the Private Placement as the subscriber has been unable to complete its subscriptions.

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company"). Further to Solarvest's news releases on May 9, 2016 and August 18, 2016 with respect to its intention to complete a non-brokered $1,500,000 debenture and unit financing (the...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") is pleased to announce that it has achieved a commercial milestone for the production of its patented DHA Omega-3 utilizing only organic inputs. Working with our contract producer, Solarvest was able to achieve yield(s) in active ingredient and cell density, that positions the Company for profitable production and launch into the premium organic nutraceutical market. The Company will launch this product in the US where it has received FDA approval as a dietary supplement and the world's first 100%

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") is pleased to announce that it has achieved a commercial milestone for the production of its patented DHA Omega-3 utilizing only organic inputs. Working with our contract...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") announced on May 9, 2016 its intention to complete a non-brokered $1,500,000 debenture and unit financing (the "Private Placement"). While the Company has been ready, willing and able to close the Private Placement for some time, certain subscribers have encountered delays in their funding arrangements and, accordingly have requested an extension to complete their subscriptions. To accommodate these subscribers, the Company has applied for and received consent from the TSXV Venture

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") announced on May 9, 2016 its intention to complete a non-brokered $1,500,000 debenture and unit financing (the "Private Placement"). While the Company has been ready, willing...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") is pleased to announce that it has executed term sheets for a debenture and a unit financing pursuant to which the Company intends to raise gross proceeds of up to $1,500,000. Formal documentation with respect to the financing is being prepared.

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") is pleased to announce that it has executed term sheets for a debenture and a unit financing pursuant to which the Company intends to raise gross proceeds of up to...

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") announces it has closed the third and final tranche of its previously announced non-brokered private placement, pursuant to which investors purchased from the Company an...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") announces it has closed the third and final tranche of its previously announced non-brokered private placement, pursuant to which investors purchased from the Company an aggregate 200,000 Units at a price of $0.25 per Unit for gross proceeds of $50,000. Each Unit consists of one common share and one warrant. Each warrant is exercisable for one common share at $0.35 for a period of eighteen months following the closing and include an acceleration clause that is triggered by a share price of $0.55

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest" or the "Company") reports that, further to the news release of March 31, 2016, the Company has received consent from the TSX Venture Exchange to extend the expiry date of certain common share...

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") reports that, further to the news release of March 31, 2016, the Company has received consent from the TSX Venture Exchange to extend the expiry date of certain common share purchase warrants, which were issued pursuant to a private placement in October 2014 (the "Warrants").

SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company") announces that it intends to amend certain common share purchase warrants in the capital of the Company, which were issued pursuant to a private placement in October 2014 (the "Warrants").